Inactive Instrument

Highlights Kindred Biosciences, Inc.

Equities

KIN

US4945771099

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Vaxart, Inc. acquired KindredBio's manufacturing equipment and GMP manufacturing facility in California from Kindred Biosciences, Inc.	21-11-30	CI
Elanco Animal Health Incorporated : Closes Purchase of Kindred Biosciences for About $444 Million	21-08-30	MT
Elanco Animal Health Incorporated completed the acquisition of Kindred Biosciences, Inc..	21-08-26	CI
Today on Wall Street: Markets ride momentum ahead of Jackson Hole	21-08-23
Kindred Biosciences, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-05	CI
Elanco Animal Health Incorporated : to Buy Kindred Biosciences for $440 Million, Eyeing Growth in Pet Dermatology Market	21-06-16	MT
Elanco Animal Health Incorporated : Agrees to Buy Kindred Biosciences for $440 Million	21-06-16	MT
Elanco Animal Health Incorporated entered into an agreement to acquire Kindred Biosciences, Inc. for approximately $420 million.	21-06-15	CI
Kindred Biosciences, Inc. Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus	21-06-02	CI
Kindred Biosciences' : Q1 Loss Shrinks, Revenue Jumps	21-05-11	MT
Kindred Biosciences, Inc. and Elanco US Inc. Enter into an Exclusive License and Collaboration Agreement	21-05-11	CI
Kindred Biosciences : Earnings Flash (KIN) KINDRED BIOSCIENCES Reports Q1 Revenue $2.4M, vs. Street Est of $2.74M	21-05-11	MT
Kindred Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-11	CI
Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy Indication	21-04-28	CI
Kindred Biosciences, Inc. Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK Study	21-04-20	CI
Kindred Biosciences : Q4 Loss Narrows. Matching Street View	21-03-16	MT
Kindred Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-16	CI
Kindred Biosciences : Earnings Flash (KIN) KINDRED BIOSCIENCES Reports Q4 Revenue $951,000, vs. Street Est of $1.05M	21-03-16	MT
Kindred Biosciences,Inc. Announces Its Submission of Efficacy Data to the United States Department of Agriculture Center for Veterinary Biologics to Support the Prophylactic Indication of KIND-030	21-02-25	CI
Kindred Biosciences, Inc. Initiates Pivotal Efficacy Study of Tirnovetmab (Interleukin-31) Monoclonal Antibody for Canine Atopic Dermatitis	20-12-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Kindred Biosciences, Inc.

Equities

KIN

US4945771099

Highlights

Filters